UNICARB 450MG INJEC belongs to a group of anti-cancer medicines used for the treatment of ovarian cancer and small-cell lung cancer. It may sometimes be used to treat other cancers. Cancer forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.

UNICARB 450MG INJEC contains 'Carboplatin'. Carboplatin acts by penetrating the cell wall and binding to the cell's DNA, stopping the cell from naturally dividing and functioning, ultimately destroying the cell. These medicines target cancer cells because they often affect rapidly dividing cells.

UNICARB 450MG INJEC is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection. You may experience nausea, diarrhoea, vomiting, thrombocytopenia (a low platelet count), peripheral neuropathy (nerves malfunction), nephrotoxicity at high doses and electrolyte disturbances. Most of these side effects of UNICARB 450MG INJEC do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

To treat your condition effectually, continue taking UNICARB 450MG INJEC for as long as your doctor has prescribed. Do not stop the UNICARB 450MG INJEC midway. Talk to your doctor before taking UNICARB 450MG INJEC if you have severe allergic reactions to UNICARB 450MG INJEC or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. UNICARB 450MG INJEC should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking UNICARB 450MG INJEC if you are pregnant or breastfeeding because this UNICARB 450MG INJEC can cause harmful effects on the unborn baby. Both women and men using this UNICARB 450MG INJEC should use birth control to avoid pregnancy.

UNICARB 450MG INJEC contains 'Carboplatin' which belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or with other chemotherapy drugs depending on your cancer type.

UNICARB 450MG INJEC should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking UNICARB 450MG INJEC. To treat your condition effectually, continue taking UNICARB 450MG INJEC for as long as your doctor has prescribed. Do not stop the UNICARB 450MG INJEC midway. Talk to your doctor before taking UNICARB 450MG INJEC if you have severe allergic reactions to UNICARB 450MG INJEC or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. UNICARB 450MG INJEC should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking UNICARB 450MG INJEC if you are pregnant or breastfeeding because this UNICARB 450MG INJEC can cause harmful effects on the unborn baby. Both women and men using this UNICARB 450MG INJEC should use birth control to avoid pregnancy. Peripheral blood counts should be frequently monitored during UNICARB 450MG INJEC treatment and appropriate until recovery is achieved.

• Peripheral blood counts should be frequently monitored during carboplatin treatment and, when appropriate, until recovery is achieved.
• UNICARB 450MG INJEC should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking UNICARB 450MG INJEC.
• Your doctor may get routine blood tests done to monitor your liver function, electrolyte levels, and blood cell count in your blood.
• Avoid unnecessary or prolonged exposure to sunlight and UV light (such as tanning booths) and wear protective clothing, sunglasses, and sunscreen. UNICARB 450MG INJEC may make your skin sensitive to sunlight.